Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod

BACKGROUND: Tobacco exposure is a modifiable risk factor for multiple sclerosis (MS). Studies evaluating the relationship between tobacco, disease activity, and disease modifying therapy (DMT) persistence yielded conflicting results. We sought to address this issue with data from clinical practice....

Descripción completa

Detalles Bibliográficos
Autores principales: Hersh, Carrie M, Harris, Haleigh, Ayers, Malissa, Conway, Devon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557793/
https://www.ncbi.nlm.nih.gov/pubmed/33110616
http://dx.doi.org/10.1177/2055217320959815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557793/
https://www.ncbi.nlm.nih.gov/pubmed/33110616
http://dx.doi.org/10.1177/2055217320959815

Ejemplares similares